WebObjectives: The recent arrival of new hepatitis C virus (HCV) drugs has brought fiscal pressures onto Medicare Part D; spending on HCV drugs in Part D jumped from $283 million in 2013 to $4.5 billion in 2014. We examined the current benefit designs for HCV drugs in Part D plans and analyzed patients' financial burden for those drugs. WebOct 3, 2024 · State Medicaid programs, which cover a high proportion of people with hepatitis C, balked at the high prices, even with the 23 percent drug discount the programs typically receive. Many threw up ...

States Deny Pricey Hepatitis C Drugs To Most Medicaid Patients

WebRising specialty drug costs pose a substantial problem for the California state budget and the problem will continue to grow. While these trends are of concern to all payers, this brief focuses on the implications for California’s Medicaid program, Medi-Cal, using the example of Sovaldi, a treatment for hepatitis C. WebMay 6, 2024 · Gilead priced its first new hepatitis C drug, sofosbuvir, at $1,000 per pill, or $84,000 for a three-month course of treatment. ... not the least the cost. If every Medicaid patient in a state ... mariah carey heritage

Medicaid and People with HIV KFF

WebDec 27, 2015 · Effective treatments for hepatitis C cost as much as $95,000. Medicaid in many states, including Indiana, is mostly limiting the drugs' use to very advanced cases. ACLU of Indiana is suing the state. WebIn addition to manufacturer's assistance programs, there are non-profit programs that provide ... WebHowever, an 8- to 12-week course can range from $54,000 to $95,000 (or higher). For example, the price of a 12-week course of Zepatier can be as much as $54,600, and a … mariah carey hero 15 youtube